FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer
The orphan drug designation is a result of positive findings from a phase 2 clinical trial which demonstrated a 100% clinical benefit rate in patients.
Biostar Pharma Utidelone Biostar Pharma Li Tang Sebastian Kaulitzki Biostar Pharma Inc Hanmi Pharmaceuticals
Source: pharmacytimes.com